Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
The methodological limitations identified, including the small number of clinical trials, reduced sample sizes, heterogeneity in interventions, ascent protocols and lack PK/PD analysis limit the strength of the available evidence
If these factors are absent, continuation may be appropriate
All product information on this website is for educational purposes only
It serves as an official record that the product has undergone rigorous testing and meets specific criteria set forth by regulatory authorities or industry standards
Chronic Heart Failure & COPD Treatment for Employees All references to Highmark in this communication are references to Highmark Inc., an independent licensee of the Blue Cross Blue Shield Association, and/or to one or more of its affiliated Blue companies
US$ 20.23
US$ 24.86
US$ 25.27
US$ 20.19
US$ 26.94
